Recombinant Mycobacterium Tuberculosis Fusion Protein

Recombinant Mycobacterium Tuberculosis Fusion Protein
Product Description

C-TST is a new diagnose method to detect Mtb infectionfor,which uses antigen-specific (ESAT6 & CFP10) immune response, same with the principle of action used in IGRAs.(1)Suitable for Large Scale LTBI Screening; 
(2)Non Cross-React with BCG Vaccine; 
(3)WHO Guideline Recommended; 
(4) Easy Use, Low Cost;

Chongqing Zhifei Biological Products Co.

  • CN
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Manufacturer/Innovator
Specifications

Chongqing Zhifei Biological Products Co.

  • CN
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Manufacturer/Innovator

More Products from Chongqing Zhifei Biological Products Co. (4)

  • Recombinant COVID-19 Vaccine(CHO Cell)

    Product Recombinant COVID-19 Vaccine(CHO Cell)

    Zifivax is the first approved Recombinant COVID vaccine, there are more than 300million doses used worldwide.
  • semaglutide

    Product semaglutide

    we can supply the semaglutide API with a good price and good quality,we are also open for the cooperation model.
  • Meningococcal Polysaccharide Vaccine

    Product Meningococcal Polysaccharide Vaccine

    Chongqing zhifei biological products co., ltd offers a wide range of products which includes meningococcal polysaccharide vaccine. Function and use: it can be used to prevent epidemic cerebrospinal meningitis caused by meningococcus group a, c, y, and w135 infection. Contact us for more information.
  • Group A, C Meningococcal Polysaccharide-Conjugate Vaccine

    Product Group A, C Meningococcal Polysaccharide-Conjugate Vaccine

    MeningACon is the first approved product in China,more than 36 million doses has been used.

Chongqing Zhifei Biological Products Co. resources (1)